Leaflet ANTITOXINA BOTULINICA ABE 500UI / 500UI / 100UI / ml solution for injection

Product code:
W71719001
Quantity:
1
Indicated for:
botulism
Route of administration:
injectable
Substance:
botulinum antitoxin (therapeutic serum)
ATC
J06AA04 — Antiinfectives for systemic use | Immune sera
Botulinum antitoxin is a treatment used to neutralize botulinum toxin, produced by the bacterium Clostridium botulinum. It is indicated in cases of botulism, a serious condition that can cause muscle paralysis and respiratory failure.

The antitoxin works by binding to free botulinum toxin in the bloodstream, preventing its effects on the nervous system. It is effective only if administered early after symptom onset, as it cannot reverse already established paralysis but can stop the progression of the disease.

It is available as an injectable solution and is administered intravenously, usually in a hospital setting under strict medical supervision.

Side effects may include fever, skin rashes, pain at the injection site, or, rarely, severe allergic reactions. Prompt administration is crucial, as botulism is a medical emergency requiring immediate intervention.

General data about ANTITOXINA BOTULINICA ABE 500UI / 500UI / 100UI / ml

Substance:
botulinum antitoxin
Date of latest medicines list:
01-06-2026
Product code:
W71719001
Concentration:
500UI / 500UI / 100UI / ml
Pharmaceutical form:
solution for injection
Quantity:
1
Product type:
Generic medicine
Price:
9004.15 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
WYTWÓRNIA SUROWIC I SZCZEPIONEK BIOMED SP. Z O.O. - POLONIA
Holder:
CN UNIFARM S.A. - ROMANIA
Number:
19/2026/01
Shelf life:
3 years